Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

USA - NASDAQ:CRWD - US22788C1053 - Common Stock

503.95 USD
+0.34 (+0.07%)
Last: 10/21/2025, 6:09:12 PM
503 USD
-0.95 (-0.19%)
After Hours: 10/21/2025, 6:09:12 PM
Fundamental Rating

4

Overall CRWD gets a fundamental rating of 4 out of 10. We evaluated CRWD against 285 industry peers in the Software industry. The financial health of CRWD is average, but there are quite some concerns on its profitability. CRWD is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
In the past year CRWD had a positive cash flow from operations.
CRWD had negative earnings in 4 of the past 5 years.
In the past 5 years CRWD always reported a positive cash flow from operatings.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD has a Return On Assets (-3.20%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -7.91%, CRWD is in line with its industry, outperforming 50.53% of the companies in the same industry.
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

The Gross Margin of CRWD (74.16%) is better than 63.51% of its industry peers.
CRWD's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CRWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
The number of shares outstanding for CRWD has been increased compared to 5 years ago.
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

CRWD has an Altman-Z score of 14.27. This indicates that CRWD is financially healthy and has little risk of bankruptcy at the moment.
CRWD has a Altman-Z score of 14.27. This is amongst the best in the industry. CRWD outperforms 90.53% of its industry peers.
CRWD has a debt to FCF ratio of 0.72. This is a very positive value and a sign of high solvency as it would only need 0.72 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.72, CRWD is doing good in the industry, outperforming 76.84% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that CRWD is not too dependend on debt financing.
The Debt to Equity ratio of CRWD (0.20) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Altman-Z 14.27
ROIC/WACCN/A
WACC10.99%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.88 indicates that CRWD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.88, CRWD perfoms like the industry average, outperforming 58.95% of the companies in the same industry.
A Quick Ratio of 1.88 indicates that CRWD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.88, CRWD is in line with its industry, outperforming 59.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

8

3. Growth

3.1 Past

CRWD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.21%.
CRWD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 79.46% yearly.
CRWD shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.46%.
The Revenue has been growing by 52.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%

3.2 Future

CRWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.11% yearly.
The Revenue is expected to grow by 21.83% on average over the next years. This is a very strong growth
EPS Next Y-4.67%
EPS Next 2Y11.32%
EPS Next 3Y17.41%
EPS Next 5Y22.11%
Revenue Next Year21.76%
Revenue Next 2Y21.82%
Revenue Next 3Y21.87%
Revenue Next 5Y21.83%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 139.21, which means the current valuation is very expensive for CRWD.
CRWD's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.77. CRWD is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 103.48, which means the current valuation is very expensive for CRWD.
CRWD's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CRWD is more expensive than 60.70% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, CRWD is valued quite expensively.
Industry RankSector Rank
PE 139.21
Fwd PE 103.48
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRWD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 121.85
EV/EBITDA N/A
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CRWD's earnings are expected to grow with 17.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.32%
EPS Next 3Y17.41%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (10/21/2025, 6:09:12 PM)

After market: 503 -0.95 (-0.19%)

503.95

+0.34 (+0.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners73.69%
Inst Owner Change-0.02%
Ins Owners3.03%
Ins Owner Change-3.55%
Market Cap126.47B
Analysts76.33
Price Target492.7 (-2.23%)
Short Float %2.64%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.62%
Min EPS beat(2)9.3%
Max EPS beat(2)9.95%
EPS beat(4)4
Avg EPS beat(4)12.71%
Min EPS beat(4)9.3%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)9.93%
EPS beat(12)12
Avg EPS beat(12)12.73%
EPS beat(16)16
Avg EPS beat(16)20.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-2%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)3
Avg Revenue beat(12)-0.49%
Revenue beat(16)7
Avg Revenue beat(16)0.28%
PT rev (1m)5.21%
PT rev (3m)3.84%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)3.38%
EPS NY rev (1m)4.43%
EPS NY rev (3m)4.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 139.21
Fwd PE 103.48
P/S 29.13
P/FCF 121.85
P/OCF 91.07
P/B 33.67
P/tB 46.4
EV/EBITDA N/A
EPS(TTM)3.62
EY0.72%
EPS(NY)4.87
Fwd EY0.97%
FCF(TTM)4.14
FCFY0.82%
OCF(TTM)5.53
OCFY1.1%
SpS17.3
BVpS14.97
TBVpS10.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.16%
FCFM 23.91%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Debt/EBITDA N/A
Cap/Depr 143.34%
Cap/Sales 8.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 14.27
F-Score3
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
EPS Next Y-4.67%
EPS Next 2Y11.32%
EPS Next 3Y17.41%
EPS Next 5Y22.11%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%
Revenue Next Year21.76%
Revenue Next 2Y21.82%
Revenue Next 3Y21.87%
Revenue Next 5Y21.83%
EBIT growth 1Y-638.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.6%
EBIT Next 3Y38.46%
EBIT Next 5Y36.81%
FCF growth 1Y29.99%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y30.79%
OCF growth 3Y33.96%
OCF growth 5Y69.1%